Nutex Health, Inc.
General ticker "NUTX" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $866.8M (TTM average)
Nutex Health, Inc. follows the US Stock Market performance with the rate: 47.7%.
Estimated limits based on current volatility of 3.6%: low 187.18$, high 201.33$
Factors to consider:
- Total employees count: 944 (+18.0%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Regulatory and compliance, Reimbursement rates decline, Capital constraints, Strategic risks and growth management, Physician retention
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [107.98$, 212.25$]
- 2026-12-31 to 2027-12-31 estimated range: [97.30$, 194.17$]
Financial Metrics affecting the NUTX estimates:
- Negative: with PPE of 19.4 at the end of fiscal year the price was high
- Positive: 15.29 < Operating cash flow per share per price, % of 22.34
- Positive: 22.58 < Operating profit margin, % of 31.49
- Negative: negative Industry operating cash flow (median)
- Positive: Return on assets ratio (scaled to [-100,100]) of 16.41 > 10.70
- Positive: Industry inventory ratio change (median), % of -0.11 <= 0
- Positive: -1.23 < Investing cash flow per share per price, % of -0.47
- Positive: -51.61 < Industry operating profit margin (median), % of -17.21
Short-term NUTX quotes
Long-term NUTX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $247.65MM | $479.95MM | $875.26MM |
| Operating Expenses | $279.42MM | $349.33MM | $599.63MM |
| Operating Income | $-31.77MM | $130.62MM | $275.62MM |
| Non-Operating Income | $-16.72MM | $-20.87MM | $-30.84MM |
| Interest Expense | $16.32MM | $19.93MM | $22.23MM |
| Income(Loss) | $-48.49MM | $109.75MM | $244.78MM |
| Taxes | $-5.07MM | $14.48MM | $64.42MM |
| Net Income(Loss)* | $-45.79MM | $52.18MM | $70.79MM |
| Stockholders Equity | $61.45MM | $132.44MM | $329.45MM |
| Assets | $398.25MM | $655.32MM | $918.52MM |
| Operating Cash Flow | $1.26MM | $23.15MM | $248.12MM |
| Capital expenditure | $9.50MM | $2.30MM | $2.53MM |
| Investing Cash Flow | $-11.24MM | $-5.61MM | $-5.24MM |
| Financing Cash Flow | $-2.27MM | $1.09MM | $-97.95MM |
| Earnings Per Share** | $-10.39 | $10.23 | $11.13 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.